Latest Neuropsychopharmacology Stories
EAST KILBRIDE, Scotland, December 1, 2014 /PRNewswire/ -- The International College of Neuropsychopharmacology (CINP) has today published a paper in Nature Reviews Drug
Many individuals rely on pharmacology for different physical or mental health issues. However, some conditions require certain pharmacology which can be described as used for something entirely different.
GERMANTOWN, Md., June 19, 2014 /PRNewswire/ -- Neuralstem, Inc.
A selective GABA inverse agonist has restored cognitive function in a mouse model of Down's syndrome (DS) and has the potential to benefit humans, French researchers have revealed.
The taste of beer can trigger dopamine release in a person’s brain, even without any effect from the alcohol it contains, researchers from the Indiana University School of Medicine have discovered.
Researchers at the Institute for Comprehensive Medical Science, Fujita Health University and the National Institute for Physiological Sciences, Japan, along with colleagues from 9 other institutions, have identified an exceptional mouse model of schizophrenia.
A group of Spanish researchers has discovered a new function of the neurotransmitter dopamine in controlling sleep regulation. Dopamine acts in the pineal gland, which is central to dictating the 'circadian rhythm' in humans—the series of biological processes that enables brain activity to adapt to the time of the day (that is, light and dark cycles).
- A political dynamiter.